Literature DB >> 29482052

Substance abuse treatment engagement, completion and short-term outcomes in the Western Cape province, South Africa: Findings from the Service Quality Measures Initiative.

Bronwyn Myers1, Petal Petersen Williams2, Rajen Govender3, Ron Manderscheid4, J Randy Koch5.   

Abstract

BACKGROUND: Optimizing the effectiveness of substance use disorder (SUD) treatment is critical in low-and middle-income countries (LMICs) with limited opportunities for SUD treatment. This is the first study to identify targets for interventions to improve the quality of SUD treatment in a LMIC.
METHOD: We explored correlates of three indicators of treatment quality (treatment engagement, completion and abstinence at treatment exit) using data from a SUD performance measurement system implemented in the Western Cape Province of South Africa. The sample included data from 1094 adult treatment episodes representing 53% of the treatment episodes in 2016. Using multivariate logistic regression analyses, we modeled socio-demographic, substance use and program correlates of treatment engagement, completion, and abstinence at treatment exit.
RESULTS: Overall, 59% of patients completed treatment (48% of patients from outpatient services). Treatment completion was associated with greater likelihood of abstinence at treatment exit. Patients were more likely to complete treatment if they engaged in treatment, were older, and had more severe drug problems (characterized by daily drug use and heroin problems) and attended programs of shorter duration. Residential treatment was associated with greater likelihood of treatment engagement, completion, and abstinence at treatment exit.
CONCLUSION: Improving rates of outpatient treatment completion will enhance the effectiveness of South Africa's SUD treatment system. Interventions that promote engagement in treatment, particularly among younger patients; reduce program length through referral to step-down continuing care; and ensure better matching of drug problem to treatment level and type could improve rates of treatment completion.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  South Africa; Substance use disorder; Treatment completion; Treatment engagement; Treatment quality

Mesh:

Year:  2018        PMID: 29482052     DOI: 10.1016/j.drugalcdep.2017.12.033

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  5 in total

1.  The Opioid Epidemic in Africa And Its Impact.

Authors:  Ann E Kurth; Peter Cherutich; Rosabelle Conover; Nok Chhun; R Douglas Bruce; Barrot H Lambdin
Journal:  Curr Addict Rep       Date:  2018-10-30

2.  A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial.

Authors:  K Sorsdahl; D J Stein; S Pasche; Y Jacobs; R Kader; B Odlaug; S Richter; B Myers; J E Grant
Journal:  Addict Sci Clin Pract       Date:  2021-01-07

3.  Using a Syndemics Framework to Understand How Substance Use Contributes to Morbidity and Mortality among People Living with HIV in Africa: A Call to Action.

Authors:  Emmanuel Peprah; Bronwyn Myers; Andre-Pascal Kengne; Nasheeta Peer; Omar El-Shahawy; Temitope Ojo; Barbara Mukasa; Oliver Ezechi; Juliet Iwelunmor; Nessa Ryan; Fatoumata Sakho; John Patena; Joyce Gyamfi
Journal:  Int J Environ Res Public Health       Date:  2022-01-19       Impact factor: 3.390

4.  Prevalence and correlates of depression and substance use disorders in emergency department populations: A cross-sectional study at East Africa's largest public hospital.

Authors:  Theddeus Iheanacho; Kaitlin R Maciejewski; Frances Ogudebe; Faith Chumo; Tracie Slade; Rebecca Leff; Christine Ngaruiya
Journal:  Afr J Emerg Med       Date:  2022-07-20

5.  Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa.

Authors:  Bronwyn Myers; J Randy Koch; Kim Johnson; Nadine Harker
Journal:  Addict Sci Clin Pract       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.